420 related articles for article (PubMed ID: 19958626)
21. Definitive irradiation in multidisciplinary management of localized Ewing sarcoma family of tumors in pediatric patients: outcome and prognostic factors.
Krasin MJ; Rodriguez-Galindo C; Billups CA; Davidoff AM; Neel MD; Merchant TE; Kun LE
Int J Radiat Oncol Biol Phys; 2004 Nov; 60(3):830-8. PubMed ID: 15465200
[TBL] [Abstract][Full Text] [Related]
22. Ewing's sarcoma: only patients with 100% of necrosis after chemotherapy should be classified as having a good response.
Albergo JI; Gaston CL; Laitinen M; Darbyshire A; Jeys LM; Sumathi V; Parry M; Peake D; Carter SR; Tillman R; Abudu AT; Grimer RJ
Bone Joint J; 2016 Aug; 98-B(8):1138-44. PubMed ID: 27482030
[TBL] [Abstract][Full Text] [Related]
23. Radiation therapy for Ewing's sarcoma: results from Memorial Sloan-Kettering in the modern era.
La TH; Meyers PA; Wexler LH; Alektiar KM; Healey JH; Laquaglia MP; Boland PJ; Wolden SL
Int J Radiat Oncol Biol Phys; 2006 Feb; 64(2):544-50. PubMed ID: 16198063
[TBL] [Abstract][Full Text] [Related]
24. Prognostic factors in patients with localized Ewing's sarcoma: the effect on survival of actual received drug dose intensity and of histologic response to induction therapy.
Delepine N; Delepine G; Cornille H; Voisin MC; Brun B; Desbois JC
J Chemother; 1997 Oct; 9(5):352-63. PubMed ID: 9373791
[TBL] [Abstract][Full Text] [Related]
25. Treatment of metastatic Ewing's sarcoma or primitive neuroectodermal tumor of bone: evaluation of combination ifosfamide and etoposide--a Children's Cancer Group and Pediatric Oncology Group study.
Miser JS; Krailo MD; Tarbell NJ; Link MP; Fryer CJ; Pritchard DJ; Gebhardt MC; Dickman PS; Perlman EJ; Meyers PA; Donaldson SS; Moore S; Rausen AR; Vietti TJ; Grier HE
J Clin Oncol; 2004 Jul; 22(14):2873-6. PubMed ID: 15254055
[TBL] [Abstract][Full Text] [Related]
26. Five-year results in Ewing's sarcoma. The Scandinavian Sarcoma Group experience with the SSG IX protocol.
Elomaa I; Blomqvist CP; Saeter G; Akerman M; Stenwig E; Wiebe T; Björk O; Alvegård TA
Eur J Cancer; 2000 May; 36(7):875-80. PubMed ID: 10785592
[TBL] [Abstract][Full Text] [Related]
27. Long-term results from the first UKCCSG Ewing's Tumour Study (ET-1). United Kingdom Children's Cancer Study Group (UKCCSG) and the Medical Research Council Bone Sarcoma Working Party.
Craft AW; Cotterill SJ; Bullimore JA; Pearson D
Eur J Cancer; 1997 Jun; 33(7):1061-9. PubMed ID: 9376188
[TBL] [Abstract][Full Text] [Related]
28. Ifosfamide-containing chemotherapy in Ewing's sarcoma: The Second United Kingdom Children's Cancer Study Group and the Medical Research Council Ewing's Tumor Study.
Craft A; Cotterill S; Malcolm A; Spooner D; Grimer R; Souhami R; Imeson J; Lewis I
J Clin Oncol; 1998 Nov; 16(11):3628-33. PubMed ID: 9817284
[TBL] [Abstract][Full Text] [Related]
29. Neoadjuvant chemotherapy for Ewing's sarcoma of bone: no benefit observed after adding ifosfamide and etoposide to vincristine, actinomycin, cyclophosphamide, and doxorubicin in the maintenance phase--results of two sequential studies.
Bacci G; Picci P; Ferrari S; Mercuri M; Brach del Prever A; Rosito P; Barbieri E; Tienghi A; Forni C
Cancer; 1998 Mar; 82(6):1174-83. PubMed ID: 9506366
[TBL] [Abstract][Full Text] [Related]
30. Non-metastatic Ewing's sarcoma family of tumors of bone in adolescents and adults: prognostic factors and clinical outcome-single institution results.
Oksüz DC; Tural D; Dincbas FÖ; Dervisoglu S; Turna H; Hiz M; Kantarci F; Ceylaner B; Koca S; Mandel NM
Tumori; 2014; 100(4):452-8. PubMed ID: 25296596
[TBL] [Abstract][Full Text] [Related]
31. Protective, elective lung irradiation in non-metastatic Ewing's sarcoma.
Marinova L; Hristozova I; Mihaylova I; Perenovska P
Radiat Prot Dosimetry; 2015 Jul; 165(1-4):492-4. PubMed ID: 26113577
[TBL] [Abstract][Full Text] [Related]
32. Predictive factors of histological response to primary chemotherapy in Ewing's sarcoma.
Bacci G; Picci P; Mercuri M; Ferrari S; Longhi A; Cesari M; Rosito P; Mancini AF; Barbieri E; Baldini N
Acta Oncol; 1998; 37(7-8):671-6. PubMed ID: 10050985
[TBL] [Abstract][Full Text] [Related]
33. Curability of Ewing's sarcoma and considerations for future therapeutic trials.
Rosen G; Caparros B; Mosende C; McCormick B; Huvos AG; Marcove RC
Cancer; 1978 Mar; 41(3):888-99. PubMed ID: 638976
[TBL] [Abstract][Full Text] [Related]
34. Long-lasting multiagent chemotherapy in adult high-risk Ewing's sarcoma of bone.
Ataergin S; Ozet A; Solchaga L; Turan M; Beyzadeoglu M; Oysul K; Arpaci F; Komurcu S; Surenkok S; Ozturk M
Med Oncol; 2009; 26(3):276-86. PubMed ID: 18989798
[TBL] [Abstract][Full Text] [Related]
35. Renal Ewing tumors.
Zöllner S; Dirksen U; Jürgens H; Ranft A
Ann Oncol; 2013 Sep; 24(9):2455-61. PubMed ID: 23761687
[TBL] [Abstract][Full Text] [Related]
36. Clinical outcome of patients with recurrent or refractory localized Ewing's sarcoma family of tumors: A retrospective report from the Japan Ewing Sarcoma Study Group.
Umeda K; Miyamura T; Yamada K; Sano H; Hosono A; Sumi M; Okita H; Kumamoto T; Kawai A; Hirayama J; Jyoko R; Sawada A; Nakayama H; Hosoya Y; Maeda N; Yamamoto N; Imai C; Hasegawa D; Chin M; Ozaki T;
Cancer Rep (Hoboken); 2021 Jun; 4(3):e1329. PubMed ID: 33452866
[TBL] [Abstract][Full Text] [Related]
37. Ewing's sarcoma of the ribs. A report from the cooperative Ewing's sarcoma study.
Ozaki T; Lindner N; Hoffmann C; Hillmann A; Rödl R; Blasius S; Link T; Winkelmann W; Jürgens H
Eur J Cancer; 1995 Dec; 31A(13-14):2284-8. PubMed ID: 8652257
[TBL] [Abstract][Full Text] [Related]
38. High-dose chemotherapy followed by autologous stem cell transplantation for adult patients With first relapse of Ewing's sarcoma: A single institution experience.
Paksoy N; Ferhatoglu F; Dogan İ; Khanmammadov N; Iribas Celik A; Gulbas Z; Başaran M
Medicine (Baltimore); 2022 Dec; 101(49):e32213. PubMed ID: 36626465
[TBL] [Abstract][Full Text] [Related]
39. Results of RS-99 protocol for childhood solid tumors.
Cai JY; Tang JY; Pan C; Xu M; Xue HL; Zhou M; Dong L; Ye QD; Jiang H; Shen SH; Chen J
World J Pediatr; 2010 Feb; 6(1):43-9. PubMed ID: 20143210
[TBL] [Abstract][Full Text] [Related]
40. Impact of chemotherapy cycles and intervals on outcomes of nonspinal Ewing sarcoma in adults: a real-world experience.
Zhang J; Huang Y; Sun Y; He A; Zhou Y; Hu H; Yao Y; Shen Z
BMC Cancer; 2019 Dec; 19(1):1168. PubMed ID: 31791278
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]